Atlas Trials

Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients

Clinical trial NCT03872024 · COMPLETED

Trial details

NCT number
NCT03872024
Sponsor
Echosens
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Obesity, MorbidLiver Fibrosis
Start date
2019-09-19
Primary completion
2022-03-24
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.